Toxicity of treatment for anal carcinoma: 2D versus 3D planning

Israel Medical Association Journal

Volumn 17, Issue 7, 2015, Pages 414-417

  Atrash, Fadi ^a   Kaidar Person, Orit ^a   Billan, Salem ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Anal cancer; Carcinoma; Radiotherapy; Toxicity

Indexed keywords

CISPLATIN; FLUOROURACIL; MITOMYCIN;

ADULT; AGED; ANUS CARCINOMA; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CHEMORADIOTHERAPY; CLINICAL ARTICLE; DIARRHEA; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LEUKOPENIA; MALE; MUCOSA INFLAMMATION; ONCOLOGICAL PARAMETERS; PROCTITIS; RADIATION DOSE; RETROSPECTIVE STUDY; SKIN TOXICITY; THREE DIMENSIONAL RADIATION; TOXICITY TESTING; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT RESPONSE; TWO DIMENSIONAL RADIATION; VIRUS DETECTION; ADVERSE EFFECTS; ANUS TUMOR; COMPARATIVE STUDY; ISRAEL; MIDDLE AGED; PATHOLOGY; PROCEDURES; RADIATION INJURIES; RADIOGRAPHY; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; ANUS NEOPLASMS; CHEMORADIOTHERAPY; FEMALE; HUMANS; ISRAEL; MALE; MIDDLE AGED; RADIATION INJURIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84937943432     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Nigro ND, Vaitkevicius VK, Considine B Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 1974; 17(3): 354–6.
2. Glynne-Jones R, Nilsson PJ, Aschele C, et al. Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol 2014; 40 (10): 1165-76.
3. Kounalakis N, Artinyan A, Smith D, Mojica-Manoso P, Paz B, Lai LL. Abdominal perineal resection improves survival for nonmetastatic adenocarcinoma of the anal canal. Ann Surg Oncol 2009; 16 (5): 1310-15.
4. Nudelman IL, Fuko V, Geller A, Fenig E, Lelchuk S. Treatment of rectal cancer by chemoradiation followed by surgery: analysis and early clinical outcome in 66 patients. IMAJ 2005; 7 (6): 377-80.
5. Belkacemi Y, Berger C, Poortmans P, et al; Rare Cancer Network. Management of primary anal canal adenocarcinoma: a large retrospective study from the Rare Cancer Network. Int J Radiat Oncol Biol Phys 2003; 56 (5): 1274-83.
6. Bilimoria KY, Bentrem DJ, Rock CE, Stewart AK, Ko CY, Halverson A. Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base. Dis Colon Rectum 2009; 52 (4): 624-31.
7. Huang K, Haas-Kogan D, Weinberg V, Krieg R. Higher radiation dose with a shorter treatment duration improves outcome for locally advanced carcinoma of anal canal. World J Gastroenterol 2007; 13 (6): 895-900.
8. Constantinou EC, Daly W, Fung CY, Willett CG, Kaufman DS, DeLaney TF. Time-dose considerations in the treatment of anal cancer. Int J Radiat Oncol Biol Phys 1997; 39 (3): 651-7.
9. Hughes LL, Rich TA, Delclos L, Ajani JA, Martin RG. Radiotherapy for anal cancer: experience from 1979–1987. Int J Radiat Oncol Biol Phys 1989; 17 (6): 1153-60.
10. John M, Pajak T, Flam M, et al. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08. Cancer J Sci Am 1996; 2 (4): 205-11.
11. Konski A, Garcia M Jr, John M, et al. Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92–08. Int J Radiat Oncol Biol Phys 2008; 72 (1): 114-18.
12. Wexler A, Berson AM, Goldstone SE, et al. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy. Dis Colon Rectum 2008; 51 (1): 73-81.
13. Janssen S, Glanzmann C, Bauerfeind P, et al. Clinical experience of SIB-IMRT in anal cancer and selective literature review. Radiat Oncol 2014 8;9:199. doi: 10.1186/1748-717X-9-199.
14. Kachnic LA, Winter K, Myerson RJ, et al. RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 2013; 86 (1): 27-33.
15. Ng M, Leong T, Chander S, et al. Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer. Int J Radiat Oncol Biol Phys 2012; 83 (5): 1455-62.
16. Salama JK, Mell LK, Schomas DA, et al. Concurrent chemotherapy and intensitymodulated radiation therapy for anal canal cancer patients: a multicenter experience. J Clin Oncol 2007; 25 (29): 4581-6.